Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus

Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus

Circulating endothelial cells (CECs) and endothelial progenitor cells (EPCs) are promising markers of vascular damage and endothelial regeneration potential. We focused on the detection of CECs and EPCs using flow cytometry with regard to analytical challenges and its suitability for routine testing...

Full description

Bibliographic Details
Main Authors: Maja Preložnik Navodnik, Katarina Reberšek, Katarina Klinar, Andrej Janež, Helena Podgornik
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Current Issues in Molecular Biology
Subjects:
flow cytometry
type 1 diabetes mellitus
endothelial progenitor cells
circulating endothelial cells
adjuvant treatment
empagliflozin
Online Access:https://www.mdpi.com/1467-3045/47/1/54

Internet

https://www.mdpi.com/1467-3045/47/1/54

Similar Items